Study About Effectiveness of Silver-Containing Textiles for Treatment of Acute Neurodermatitis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

32 participants

Study Classification

INTERVENTIONAL

Study Start Date

2004-01-31

Study Completion Date

2004-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to investigate whether the treatment of acute neurodermitis with silver-contained textiles is equivalent or more effective to the conservative exogenous treatment with a corticosteroid. Secondary aim is to define skin comfortability of the textiles.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neurodermatitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

silver-contained textiles

Intervention Type DEVICE

corticosteroid

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Clinical diagnosis of acute Neurodermitis
* Age: 2-70 years
* Patients are mobile
* Patient's information and willingness to participate

Exclusion Criteria

* Acute viral infection (herpes zoster, eczema herpeticum)
* Acute staphylodermas
* Other skin-diseases affecting outcomes of intervention (e.g. psoriasis)
* Current UV-Treatment
* Current other immunosuppressive or immunomodulated Therapy
* Current antimicrobial Therapy (e.g. antibiotics)
* Severe general diseases (e.g. melanoma, renal insufficiency, autoimmune diseases)
* Pregnancy
* Fertile females without effective contraception

Minimum Eligible Age

2 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Michael Jünger, Prof. Dr.

Role: PRINCIPAL_INVESTIGATOR

Clinic and Polyclinic of Dermatology, University of Greifswald

Andrea Ladwig

Role: STUDY_CHAIR

Clinic and Polyclinic of Dermatology, University of Greifswald

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clinic and Polyclinic of Dermatology, Ernst-Moritz-Arndt-University of Greifswald

Greifswald, Fleischmannstr. 42-44, Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

III PV 08/03

Identifier Type: -

Identifier Source: org_study_id